Chicago, IL, United States of America

Alfred Guirguis

This inventor holds 1 USPTO granted patent. Top assignee: Myriad Genetics, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alfred Guirguis. Retrieved from https://idiyas.com/inventor/alfred-guirguis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alfred Guirguis: Innovator in Gene Copy Number Profiling

Introduction: Alfred Guirguis, an accomplished inventor based in Chicago, IL, has made significant strides in the field of genetic analysis. With a focus on enhancing our understanding of tumors, his innovation in gene copy number profiling sheds light on the complexities of cancer treatment.

Latest Patents: Alfred holds a patent in the area of gene copy number profiling. This invention revolves around the analysis of copy number profiles, aiming to assess whether two or more separate tumors within an individual stem from a common source. This cutting-edge technology is crucial for tailoring specific treatment protocols.

Career Highlights: Throughout his career, Alfred Guirguis has demonstrated a commitment to pushing the boundaries of genetic research. His work at Myriad Genetics, Inc. emphasizes his role in advancing the medical field, specifically in understanding oncological concerns.

Collaborations: Alfred's path has intersected with talented individuals like Kirsten Timms and Alexander Gutin. These collaborations reflect a shared vision of innovation and excellence within the scientific community, fostering advancements that can significantly impact patient care.

Conclusion: Alfred Guirguis stands out as an inventive force in the realm of gene copy number profiling. His contributions not only illuminate the challenges posed by cancer but also pave the way for personalized medicine and improved patient outcomes. Through his work at Myriad Genetics, Inc., and collaboration with esteemed colleagues, he continues to inspire the next generation of innovators in the field of genetic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…